C4 Therapeutics, Inc. Research And Development Expense

• C4 Therapeutics, Inc. showed a decrease of -5.8% in Research And Development Expense from 2024 to 2025.
• This data is from C4 Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on February 26, 2026.
• XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 7 years of available data (2019 to 2025), C4 Therapeutics, Inc.'s Research And Development Expense has grown by 116.9%.
• Historical annual values: Fiscal year 2025: $104.24 million | Fiscal year 2024: $110.64 million | Fiscal year 2023: $117.71 million | Fiscal year 2022: $117.84 million | Fiscal year 2021: $94.67 million | Fiscal year 2020: $78.44 million | Fiscal year 2019: $48.06 million.
• Data sourced from SEC EDGAR public filings as of June 20, 2026.

Last verified: June 20, 2026